| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |